Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Viemed Healthcare (VMD) Depreciation Expense (2018 - 2023)

Viemed Healthcare filings provide 6 years of Depreciation Expense readings, the most recent being $419000.0 for Q3 2023.

  • On a quarterly basis, Depreciation Expense rose 43.99% to $419000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $5.3 million, a 181.13% increase, with the full-year FY2022 number at $15.6 million, up 1736.66% from a year prior.
  • Depreciation Expense hit $419000.0 in Q3 2023 for Viemed Healthcare, up from $298000.0 in the prior quarter.
  • In the past five years, Depreciation Expense ranged from a high of $4.4 million in Q4 2022 to a low of -$7.3 million in Q4 2021.
  • Median Depreciation Expense over the past 5 years was $237000.0 (2022), compared with a mean of $17736.8.
  • Biggest five-year swings in Depreciation Expense: surged 579.61% in 2019 and later tumbled 2909.95% in 2020.
  • Viemed Healthcare's Depreciation Expense stood at $211000.0 in 2019, then tumbled by 2909.95% to -$5.9 million in 2020, then dropped by 23.82% to -$7.3 million in 2021, then surged by 159.57% to $4.4 million in 2022, then crashed by 90.42% to $419000.0 in 2023.
  • The last three reported values for Depreciation Expense were $419000.0 (Q3 2023), $298000.0 (Q2 2023), and $240000.0 (Q1 2023) per Business Quant data.